Edition:
United States

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

12.45USD
18 Jan 2019
Change (% chg)

-- (--)
Prev Close
$12.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
79,325
52-wk High
$15.08
52-wk Low
$8.11

Chart for

About

ChemoCentryx, Inc. is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of its drug candidates focuses on a specific chemoattractant receptor that selectively blocks its negative inflammatory or suppressive response, leaving... (more)

Overall

Beta: 1.56
Market Cap(Mil.): $404.27
Shares Outstanding(Mil.): 48.71
Dividend: --
Yield (%): --

Financials

  CCXI.OQ Industry Sector
P/E (TTM): -- 30.48 33.71
EPS (TTM): -0.62 -- --
ROI: -27.86 14.98 14.48
ROE: -59.68 16.31 15.99

BRIEF-Vifor Pharma Increases Equity Investment In ChemoCentryx

* INCREASES EQUITY STAKE IN CHEMOCENTRYX FROM 6.6% TO 21.2% Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 18 2018

Earnings vs. Estimates